BNB Surges to All-Time High Driven by Institutional Treasury Adoption

Binance Coin (BNB), the native token powering the Binance ecosystem, achieved a historic milestone today, reaching an all-time high of $881. This surge underscores BNB’s robust momentum throughout 2025, even as it competes with the spotlight cast by Bitcoin and Ethereum and their significant gains. BNB’s climb has solidified its position as a top-tier cryptocurrency, driven by a wave of institutional investment and growing corporate adoption. Despite a slight retreat to $842 as of our reporting time, BNB’s performance signals its increasing relevance in the crypto market.

BNB’s upward trajectory has been impressive, with a 27% price increase over the past 90 days and a nearly 50% gain over the last year. This rally has propelled BNB’s market value past Solana by approximately $19 billion, securing its rank as the fifth-largest crypto by market capitalization. A notable 29% price surge in July further highlighted BNB’s appeal, particularly among institutional investors seeking to diversify their portfolios. Companies like Nano Labs, a technology firm, and Windtree Therapeutics, a pharmaceutical enterprise, collectively invested around $610 million in BNB during July, reflecting a broader trend of corporate treasury diversification into cryptocurrencies.

The trend of corporations integrating digital assets into their balance sheets gained prominence with Strategy, which began accumulating Bitcoin in August 2020 under founder Michael Saylor. Strategy’s stock price has soared nearly 500% since adopting this approach, setting a precedent for others. The success of such strategies has inspired companies to explore tokens like BNB, which benefits from its deep integration with Binance’s expansive ecosystem, including trading, staking, and decentralized finance applications. BNB’s record high underscores its growing reputation as a reliable asset for institutional investors navigating the volatile crypto landscape.

Windtree Therapeutics’ BNB Bet Falters with Nasdaq Delisting

While BNB’s rally has been a boon for many investors, not all corporate forays into cryptocurrency have yielded positive outcomes, as evidenced by Windtree Therapeutics’ recent struggles. The Warrington, Pennsylvania-based biotech announced in July 2025 its plan to build a BNB treasury, aiming to raise up to $200 million to acquire the token. Initially, the strategy sparked a 30% surge in Windtree’s stock price, positioning it as the first Nasdaq-listed company to adopt a BNB-focused treasury. However, the enthusiasm was short-lived, with the stock plummeting 90% from its peak, falling to just $0.11 by August 21, 2025.

Windtree’s sharp decline triggered a violation of Nasdaq’s Listing Rule 5550(a)(2), which requires a minimum bid price of $1 per share. On Tuesday, the company disclosed that Nasdaq would suspend trading of its shares effective August 21, 2025, forcing a transition to over-the-counter (OTC) markets under the ticker WINT, pending approval. The delisting undermines Windtree’s ambitious pivot to cryptocurrency, raising questions about the viability of such strategies for companies with shaky financial foundations. While Windtree maintains that its core operations remain unaffected, the move to OTC trading could limit liquidity and investor access, further complicating its path forward.

The contrasting fortunes of BNB and Windtree highlight the opportunities and risks in the evolving crypto market. BNB’s record-breaking performance reflects strong fundamentals and institutional confidence, while Windtree’s delisting serves as a warning for companies chasing crypto-driven growth without a sustainable business model. As BNB continues to attract corporate interest, its $881 peak marks a significant moment in its ascent, even as firms like Windtree grapple with the challenges of integrating digital assets into traditional financial strategies.